Gisens Biotech
PrivateLast Round
Accelerator
Sep 13, 2024
Est. Valuation
$2.61M
Total Funding Raised
$315,000
Momentum Score
25 /100
Company Overview
Gisens Biotech is a point-of-care diagnostic company developing a platform based on a graphene biochip to deliver rapid, real-time health monitoring. The company's proprietary G-LoC technology analyzes a patient's sample, such as saliva or blood, to provide results in minutes with high accuracy. Its initial product, KF4+, is a comprehensive kidney function test designed for at-home use by patients with chronic kidney disease (CKD), measuring key biomarkers and integrating results into the patient's electronic health record. The technology uses a graphene-based chip functionalized with recognition molecules that bind to specific biomarkers, triggering electrical changes that are interpreted to generate a molecular signature. The company was founded in 2019 and has participated in several accelerator programs.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials, Sensors, Health IoT
Business Model
B2B2C
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gisens Biotech Comps
Public and private peers based on sector, stage, and business model.
Gisens Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 13, 2024 | ||||
| Accelerator | Aug 29, 2024 | ||||
| Accelerator | May 16, 2023 | ||||
| Grant | Mar 2, 2021 |
Key People
Founding team and executive leadership
Gisens Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Activation Capital | Accelerator |
| gener8tor | Accelerator |
| Techstars | Accelerator |
| UNT Health Science Center | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Monthly visitors grew 92% MoM.
- Oct 3, 2025
Added Berkeley, a higher education institution, as a customer.
Gisens Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gisens Biotech's valuation, stock price, and market status.
